The SPOTLIGHT study is a Phase 1b/2a open label clinical trial evaluating a single dose of subcutaneous briquilimab in adult participants with cold urticaria (ColdU ... and tolerability of briquilimab ...

Not all moisturisers are actually good at reducing moisture loss. You may still itch as your skin recovers if you’ve been ...

Usually restricted to areas of skin contact. Contact urticaria, (nonimmunologic) Seconds to minutes Minutes to hours Toxin-mediated. Immediate reaction, with urticaria, erythema, edema ...

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.

Alys Pharmaceuticals announces CTA submission for ALY-301, the first mast cell selective c-Kit inhibitor for treatment of Cold Urticaria 10 June 2025 DeepCure Announces DC-15442 as Development ...